Delivery Order SPE2DB20D1047-SPE2DB24FF84W
Award Date
8/29/24
Potential Completion Date
8/30/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of a pharmaceutical product - ADBRY 150 MG/ML SYRINGEML. The order has a ceiling value of $17,638.32 and a period of performance through August 13, 2024. It is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued at up to $999,999,999, which provides a broad range of medical commodities to support military...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,028.98 contract is for the delivery of ADBRY 150 MG/ML SYRINGEML pharmaceutical products to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADBRY 150 MG/ML SYRINGEML, with a ceiling value of $6,664.23 and a period of performance through May 16, 2025. The contract is not set aside and is a firm-fixed price delivery order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,041.76 firm fixed-price contract is for the supply of ADBRY 150 MG/ML syringes and has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This is a $6,549.28 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ADBRY 150 MG/ML SYRINGEML, a medical product, with a period of performance through June 27, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has a ceiling value of $17,238.42 and a period of performance through January 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
The U.S. Defense Logistics Agency (DLA) awarded a $9,201.62 firm-fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with a completion date of April 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a broad range...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,090.38 firm fixed price contract is for the medical product ADBRY 150 MG/ML SYRINGE. It is not a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product, with a potential value of $6,975.59. The delivery order has a completion date of December 27, 2023. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside...
This is a $6,244.74 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a pharmaceutical product. The contract has a completion date of July 3, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...